Patricia Drake
Corporate Officer/Principal at TREVENA, INC.
Net worth: 41 760 $ as of 31/05/2024
Patricia Drake active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11/11/2021 | - |
Career history of Patricia Drake
Former positions of Patricia Drake
| Companies | Position | Start | End |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2021 | 01/09/2021 |
| MSD Finland Oy | Chief Executive Officer | 01/01/2019 | 01/05/2021 |
Training of Patricia Drake
| Wichita State University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Finland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
- Stock Market
- Insiders
- Patricia Drake
- Experience
